JPRN-UMIN000020984招募中未知
The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors in Japanese patients with type 2 diabetes. - The clinical study to explore the effects of SGLT2-inhibitors or DPP-4 inhibitors.
Showa University School of Medicine, Division of Diabetes and Endocrinology, Department of Internal Medicine0 个研究点目标入组 160 人开始时间: 2016年2月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who are acute disease 2.Patients who are past history of hypersensitivity to anagliptin 3.Pregnant or woman of child-bearing potential 4.Patients whose eGFR are within 60mL/min/1.73m2 5.Patients who are judged as inappropriate for inclusion by phsicians
研究者
相似试验
招募中
不适用
A study on multifaceted clinical effects of SGLT2 inhibitorstype 2 diabetesJPRN-UMIN000031947Tokushima University123
已完成
不适用
Prospective intervention study of novel SGLT-2 inhibitor ipragliflozin in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000015104Seino Naika Clinic100
招募中
不适用
Efficacy of the selective SGLT2 Inhibitor for Glycogen Storage Disease Type 1bGlycogen Storage Disease type 1bCarbohydrate Metabolism, Inborn ErrorsD005953JPRN-jRCTs071210064akanishi Koichi5
进行中（未招募）
不适用
RESTORE-nephropathy studyType 2 diabetes mellitusD003924Diabetes Mellitus, Type 2JPRN-jRCTs031190185Tanaka Masami47
已完成
Unknown
Prospective observational study of tofogliflozin in patients with type 2 diabetesType 2 DiabetesJPRN-jRCT1090220212agoya Medical Association600